Search
for
Sort by
Research 931–960 of 1000+
- British Hair and Nail Society
- Skin Diseases (Noncancerous)
- BH07: Testosterone deficiency in men with female pattern hair loss
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- What causes hidradenitis suppurativa ?—15 years after
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Comorbidities in patients with lichen planopilaris: A retrospective case-control study
- Preparation and Optimization of Garlic Oil/Apple Cider Vinegar Nanoemulsion Loaded with Minoxidil to Treat Alopecia
- Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- The Role of T‐Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis
- Janus Kinase inhibitors in dermatology: a review
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Novel drugs of United States Food and Drug Administration approved in 2024
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- A Cross-Sectional Analysis of Psychological and Dermatologic Manifestations Post-February 6 Earthquakes in Dermatology Patients
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Prevalence of Clinical Manifestations Known to Be Associated With Insulin Resistance Among Female Medical Students of a Private College in Saudi Arabia